O papel Do ácido Tranexamico na rinoplastia
Ver/
Trabajo
(application/pdf: 350.0Kb)
(application/pdf: 350.0Kb)
Autorización
(application/pdf: 481.7Kb)
(application/pdf: 481.7Kb)
Similitud
(application/pdf: 243.8Kb)
(application/pdf: 243.8Kb)
Fecha
2022Autor(es)
Cevallos Mesías, Janet Jesús
Asesor(es)
Bustani Loss, Luciano
ORCID(s) de asesor(es)
https://orcid.org/0000-0002-7729-5906
Metadatos
Mostrar el registro completo del ítemResumen
In this article we aim to demonstrate the role of tranexamic acid in patients
undergoing Rhinoplasty and discuss the effects on postoperative recovery.
We performed a review of articles where the mechanism of action and
postoperative effects are evaluated. Sakallioglu et al. described the oral
administration of tranexamic acid at a dosage of 1g before surgery,
followed by 1g 3x/day for 5 days postoperatively, demonstrating statistical
significance in reducing intraoperative blood loss. Ghavimi et al.
demonstrated the intravenous use of tranexamic acid at 10mg/kg, with a
reduction in edema, bleeding and periorbital ecchymosis, in addition to
Vasconcellos et al., who made a comparison between the use of tranexamic
acid and placebo, proving a significant decrease in bleeding peri- and
postoperatively. Tranexamic acid is a drug that has been increasingly used
in plastic surgery, and considering its clinical relevance and the results
observed in literature reviews of previously published studies, we can
justify its routine use in rhinoplasty.
Colecciones
Editor
Universidad de San Martín de Porres
Tipo de investigación
https://purl.org/pe-repo/renati/type#trabajoAcademico
Acceso
info:eu-repo/semantics/openAccess
Notas
Modalidad de obtención de segunda especialidad sin designación de jurado según Oficio N.° 009-2025–OGYT-FMH/USMP